Search

Author/Creator Quaresima, Micol

1. A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma. Issue 1 (1st November 2020)

Authors:
Rocchi, Serena; Tacchetti, Paola; Pantani, Lucia; Mancuso, Katia; Rizzello, Ilaria; di Giovanni Bezzi, Chiara; Scalese, Marco; Dozza, Luca; Marzocchi, Giulia; Martello, Marina; Barilà, Gregorio; Antonioli, Elisabetta; Staderini, Michela; Buda, Gabriele; Petrini, Mario; Cea, Michele; Quaresima, Mi...
Journal:
Hematological oncology
Issue:
Volume 39:Issue 1(2021)
Page Start:
41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

Authors:
Quaresima, Micol; Quaresima, Virginia; Naldini, Matteo Maria; Cirillo, Daniela Maria; Ferrari, Angela; Mazzi, Angela; Tesini, Ester Maria Carla; Leone, Maria Cristina; Merli, Francesco
Journal:
EJHaem
Issue:
Volume 1:Issue 1(2020)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

Authors:
Quaresima, Micol; Quaresima, Virginia; Naldini, Matteo Maria; Cirillo, Daniela Maria; Ferrari, Angela; Mazzi, Angela; Tesini, Ester Maria Carla; Leone, Maria Cristina; Merli, Francesco
Journal:
EJHaem
Issue:
Volume 1:Issue 1(2020)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity. Issue 1 (4th July 2020)

Authors:
Quaresima, Micol; Quaresima, Virginia; Naldini, Matteo Maria; Cirillo, Daniela Maria; Ferrari, Angela; Mazzi, Angela; Tesini, Ester Maria Carla; Leone, Maria Cristina; Merli, Francesco
Journal:
EJHaem
Issue:
Volume 1:Issue 1(2020)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry. Issue 3 (29th April 2014)

Authors:
Biasoli, Irene; Cesaretti, Marina; Bellei, Monica; Maiorana, Antonino; Bonacorsi, Goretta; Quaresima, Micol; Salati, Massimiliano; Federico, Massimo; Luminari, Stefano
Journal:
Hematological oncology
Issue:
Volume 33:Issue 3(2015:Sep.)
Page Start:
147
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection. Issue 2 (10th December 2021)

Authors:
Longo, Filomena; Gianesin, Barbara; Voi, Vincenzo; Motta, Irene; Pinto, Valeria Maria; Piolatto, Andrea; Spasiano, Anna; Ruffo, Giovan Battista; Gamberini, Maria Rita; Barella, Susanna; Mariani, Raffaella; Fidone, Carmelo; Rosso, Rosamaria; Casale, Maddalena; Roberti, Domenico; Dal Zotto, Chiara;...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 2(2022)
Page Start:
E75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis. (27th July 2013)

Authors:
Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Liardo, Eliana V.; Marcheselli, Raffaella; Luminari, Stefano; Quaresima, Micol; Cirilli, Claudia; Ferri, Paola; Federico, Massimo; Sacchi, Stefano
Journal:
British journal of haematology
Issue:
Volume 163:Number 1(2013:Oct.)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗